Benzinga | Jun 22, 2021 05:25AM EDT

Jefferies Initiates Coverage On Centessa Pharmaceuticals with Buy Rating, Announces Price Target of $35

Jefferies analyst Eun Yang initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating and announces Price Target of $35.